Prometheus Helidac
Executive Summary
San Diego-based Prometheus acquires Procter & Gamble's H. pylori triple therapy (bismuth subsalicylate/metronidazole/tetracycline)You may also be interested in...
Procter & Gamble Recants: Size Does Matter In Rx Industry
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Need a specific report? 1000+ reports available
Buy Reports